Skip to main content
. 2017 Dec;8(6):945–952. doi: 10.21037/jgo.2017.06.06

Table 4. Best recorded response.

Evaluable population (N=24) Number subjects, N [%]
CR 0 [0]
PR 3 [13]
ORR 3 [13]
SD 13 [54]
DCR 16 [67]
PD 8 [33]
Not evaluable 16 [67]

CR, complete response per RECIST; PR, partial response per RECIST; ORR, overall response rate (CR + PR); SD, stable disease per RESIST; DCR, ORR + SD; PD, progressive disease per RECIST.